US buys 600K doses of new COVID antibody awaiting clearance
WASHINGTON (AP) — Addressing diminished treatment options in the omicron wave, the Biden administration has purchased enough of a yet-to-be approved antibody drug to treat 600,000 COVID-19 patients, officials said Thursday. The new monocl...




